Financing
Debt Issuance Costs
Guardant Health Debt Issuance Costs decreased by 99.2% to $102K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.2%, from $12.14M to $102K. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalLower is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher costs may indicate complex financing arrangements or a higher risk profile requiring more expensive underwriting.
Detailed definition
Represents the cash outflows associated with the legal, accounting, and underwriting fees incurred to secure debt financ...
Peer comparison
Standard across all capital-intensive firms; typically correlates with the size and complexity of debt issuances.
Metric ID:
payment_of_debt_issuance_costsHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12.14M | $151K | $0 | $12.3M | $102K |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | — | — | -98.8% | -100.0% | — | -99.2% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -99.2% |
Range$0 – $12.3M
Avg YoY Growth-99.2%
Median YoY Growth-99.2%
Debt Issuance Costs at Other Companies
Frequently Asked Questions
- What is Guardant Health's debt issuance costs?
- Guardant Health (GH) reported debt issuance costs of $102K in Q1 2026.
- How has Guardant Health's debt issuance costs changed year-over-year?
- Guardant Health's debt issuance costs decreased by 99.2% year-over-year, from $12.14M to $102K.
- What does debt issuance costs mean?
- Cash spent on fees to obtain debt financing.